BR112013001642A8 - coacoplamento para controlar a reatividade de reagentes em imunoensaios - Google Patents

coacoplamento para controlar a reatividade de reagentes em imunoensaios

Info

Publication number
BR112013001642A8
BR112013001642A8 BR112013001642A BR112013001642A BR112013001642A8 BR 112013001642 A8 BR112013001642 A8 BR 112013001642A8 BR 112013001642 A BR112013001642 A BR 112013001642A BR 112013001642 A BR112013001642 A BR 112013001642A BR 112013001642 A8 BR112013001642 A8 BR 112013001642A8
Authority
BR
Brazil
Prior art keywords
coupling
immunoassays
reagents
control reactivity
reactivity
Prior art date
Application number
BR112013001642A
Other languages
English (en)
Other versions
BR112013001642A2 (pt
Inventor
Harold Baker
Michaela Hoffmeyer
Sherry Dunbar
Original Assignee
Luminex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luminex Corp filed Critical Luminex Corp
Publication of BR112013001642A2 publication Critical patent/BR112013001642A2/pt
Publication of BR112013001642A8 publication Critical patent/BR112013001642A8/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

coacoplamento para controlar a reatividade de reagentes em imunoensaios. a presente invenção refere-se a métodos e composições para controlar a reatividade de imunoensaio. em uma modalidade, um método para a preparação de um substrato para um imunoensaio é fornecido em que uma composição que contém um reagente e um material neutro é aplicada a um substrato sob condições adequadas para acoplar o reagente e o material neutro com o substrato.
BR112013001642A 2010-07-23 2011-07-22 coacoplamento para controlar a reatividade de reagentes em imunoensaios BR112013001642A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36728110P 2010-07-23 2010-07-23
PCT/US2011/045053 WO2012012748A2 (en) 2010-07-23 2011-07-22 Co-coupling to control reactivity of reagents in immunoassays

Publications (2)

Publication Number Publication Date
BR112013001642A2 BR112013001642A2 (pt) 2016-05-24
BR112013001642A8 true BR112013001642A8 (pt) 2016-10-11

Family

ID=45494106

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013001642A BR112013001642A8 (pt) 2010-07-23 2011-07-22 coacoplamento para controlar a reatividade de reagentes em imunoensaios

Country Status (9)

Country Link
US (2) US20120021944A1 (pt)
EP (1) EP2596354B1 (pt)
JP (1) JP5813111B2 (pt)
KR (1) KR101866844B1 (pt)
CN (1) CN103026230B (pt)
AU (1) AU2011280967B2 (pt)
BR (1) BR112013001642A8 (pt)
CA (1) CA2806306A1 (pt)
WO (1) WO2012012748A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014306363B2 (en) * 2013-08-13 2019-05-02 Anteo Technologies Pty Ltd Conjugating molecules to particles
WO2015106226A2 (en) * 2014-01-10 2015-07-16 University Of Rochester Diagnostic device and method for detection of staphylococcus infection
US10802023B2 (en) * 2014-10-30 2020-10-13 Erasmus University Medical Center Rotterdam Reagents, methods and kits for diagnosing primary immunodeficiencies
JP6218916B1 (ja) 2016-12-28 2017-10-25 Jsr株式会社 磁性粒子分散液
CN110187132A (zh) * 2019-05-14 2019-08-30 太原瑞盛生物科技有限公司 一种检测促甲状腺激素的分析方法
CN111879946A (zh) * 2020-07-28 2020-11-03 江苏扬新生物医药有限公司 一种多指标快速检测荧光免疫层析试剂盒

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4357311A (en) * 1980-10-03 1982-11-02 Warner-Lambert Company Substrate for immunoassay and means of preparing same
US4812414A (en) * 1987-09-18 1989-03-14 Eastman Kodak Company Immunoreactive reagent particles having tracer, receptor molecules and protein of pI less than 6
DE3882058T2 (de) * 1987-02-27 1994-01-13 Eastman Kodak Co Immunoreaktives Reagens, Verfahren zu seiner Herstellung und seine Verwendung zur Bestimmung einer immunoreaktiven Spezies.
WO1988007670A2 (en) * 1987-03-27 1988-10-06 Chimerix Corporation Time-resolved fluorescence apparatus and immunoassay
US5047326A (en) * 1988-10-07 1991-09-10 Eastman Kodak Company Immunmological reagent composition and its use in the determination of chlamydial or gonococcal antigens
FR2654836B1 (fr) * 1989-11-17 1994-01-28 Biotrol Sa Laboratoires Appareil d'execution automatique d'un immunodosage en plusieurs etapes successives d'au moins une substance biologique dans une pluralite d'echantillons biologiques, procede et reactif mettant en óoeuvre ledit appareil.
US5143825A (en) * 1990-03-01 1992-09-01 Abbott Laboratories Stabilized substrate for use in an immunoassay
FR2709492B1 (fr) * 1993-09-03 1995-11-24 Bioxytech Méthode d'immunodosage spécifique de la glutathion peroxydase plasmatique humaine, kit pour sa mise en Óoeuvre, oligopeptides et anticorps spécifiques de la méthode .
GB9420355D0 (en) * 1994-10-10 1994-11-23 Univ Nottingham Preparation of protein microspheres, films and coatings
US5736330A (en) 1995-10-11 1998-04-07 Luminex Corporation Method and compositions for flow cytometric determination of DNA sequences
JP2004500569A (ja) * 2000-02-25 2004-01-08 ルミネックス コーポレイション 多重アッセイ法のための内部標準および内部対照
US9709559B2 (en) * 2000-06-21 2017-07-18 Bioarray Solutions, Ltd. Multianalyte molecular analysis using application-specific random particle arrays
US6528321B1 (en) * 2000-06-26 2003-03-04 Beckman Coulter, Inc. Opposable-element chromatographic assay device for detection of analytes in whole blood samples
FR2855613B1 (fr) * 2003-05-26 2005-08-19 Biocytex Procede de detection et de quantification multiplex d'analytes dans un echantillon a l'aide de microspheres
US7527980B2 (en) * 2004-08-18 2009-05-05 Florida State University Research Foundation Indirect detection of cardiac markers for assessing acute myocardial infarction
US7527979B2 (en) * 2004-08-18 2009-05-05 Florida State University Research Foundation Devices and methods for rapid detection of pathogens
AU2005319367B2 (en) * 2004-12-20 2012-05-24 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
JP2008527332A (ja) * 2004-12-31 2008-07-24 ジェネンテック・インコーポレーテッド 非ヒト血清中におけるヒト抗体の検出
US7396689B2 (en) * 2005-02-04 2008-07-08 Decision Biomarkers Incorporated Method of adjusting the working range of a multi-analyte assay
WO2007026408A1 (ja) * 2005-08-30 2007-03-08 Osaka University 生物学的実験に用いることができる安定な標識媒体
EP1777521A1 (en) * 2005-10-20 2007-04-25 PENTAX Corporation Method and kit for the determination of HIV infection
KR101485303B1 (ko) * 2006-09-21 2015-01-22 네스텍 소시에테아노님 희귀 순환세포 내의 다수의 신호전달인자를 검출하기 위한 항체 기반 분석법
EP2544001A3 (en) * 2006-10-18 2013-04-24 Axela Inc. Measuring multiple analytes over a broad range of concentrations using optical diffraction
EP2240778B1 (en) * 2008-01-07 2014-07-23 Luminex Corporation Isolation and identification of cells from a complex sample matrix
CN101545912A (zh) * 2008-03-25 2009-09-30 北京科美东雅生物技术有限公司 胰岛素微孔板式磁颗粒化学发光免疫分析测定试剂盒及其制备方法
WO2009152269A2 (en) * 2008-06-11 2009-12-17 Health Research, Inc. Methods of quantifying biomarkers
WO2010054385A2 (en) * 2008-11-10 2010-05-14 Luminex Corporation Method and system for manufacture and use of macroporous beads in a multiplex assay

Also Published As

Publication number Publication date
US20140024556A1 (en) 2014-01-23
BR112013001642A2 (pt) 2016-05-24
EP2596354B1 (en) 2017-04-12
WO2012012748A3 (en) 2012-05-10
US20120021944A1 (en) 2012-01-26
JP5813111B2 (ja) 2015-11-17
WO2012012748A2 (en) 2012-01-26
CA2806306A1 (en) 2012-01-26
JP2013532821A (ja) 2013-08-19
AU2011280967A1 (en) 2013-01-31
EP2596354A2 (en) 2013-05-29
AU2011280967B2 (en) 2014-09-11
CN103026230B (zh) 2015-01-14
EP2596354A4 (en) 2013-12-25
KR101866844B1 (ko) 2018-06-14
CN103026230A (zh) 2013-04-03
KR20130090892A (ko) 2013-08-14

Similar Documents

Publication Publication Date Title
BR112013001642A2 (pt) coacoplamento para controlar a reatividade de reagentes em imunoensaios
BR112013022480A2 (pt) processo para determinação de propriedade de combustível
BR112012027147A2 (pt) método in vitro destinado à liberação de um composto de vitamina d e à medição de um composto de vitamina d, composição e mistura de reagente, uso de uma composição de reagente e kits
BR112012010099A2 (pt) métodos de cimentação em formações subterrâneas usando pó da calcinação do cimento em composições apresentando reduzido teor de cimento portland
BR112012026919A2 (pt) aglutinantes
BR112013012997A2 (pt) elementos de construção em forma de painel
CL2012000258A1 (es) Proceso para la preparacion de composicion de aglomerante hidraulico asperjable que contiene como principales componentes agua, agregados, aglomerante hidraulico, acelerador de fraguado, aglomerante hidraulico asperjable; composicion; y uso
WO2012064071A3 (ko) 점착제 조성물
BR112012033091A2 (pt) método de cimentação, e, composição de cimento
BR112012032246A2 (pt) adesivo intercalado, estrutura impermeável e método de construção impermeável
DOP2014000093A (es) Compuestos con actividad nematicida
DOP2014000090A (es) Compuestos con actividad nematicida
BR112015012539A2 (pt) dispositivo de exibição e método de controle do mesmo
UY35168A (es) Composiciones y métodos de anticuerpos de marcaje de epo
BR112015013984A2 (pt) métodos para o tratamento de prurido
BR112016008502B8 (pt) Composição refrigerante
BR112012027793A8 (pt) Método para a purificação de uma proteína de ligação de cátion divalente
CU24484B1 (es) Panel de construcción que posee una fuerza de fijación mejorada
BR112015032393A2 (pt) processo para a preparação estereosseletiva de uma pirazol-carboxamida
BR112015011515A2 (pt) Composições farmacêuticas de inibidores de cetp
BR112013005148A2 (pt) transformador de fases múltiplas com fases acopladas magneticamente
WO2011095883A3 (en) Compounds and compositions for susceptor materials
DE112010004277A5 (de) Zweikomponentige klebstoff- oder dichtstoffzusammensetzung mit beschleunigerkomponente
BR112013000406A2 (pt) detecção de metabólitos alvos
TR201900996T4 (tr) Alçı sıva astarında veya selüloz eter içeren dolgu bileşimlerinde aglomerasyonu azaltma yöntemi.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2524 DE 21-05-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.